Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin
The concept that hepatic cholesterol synthesis regulates hepatocyte assembly and secretion of apoB-containing lipoproteins remains controversial. The present study was carried out in HepG2 cells to examine the regulation of apoB secretion by the HMG-CoA reductase inhibitor atorvastatin. ApoB accumul...
Main Authors: | Lisa J. Wilcox, P. Hugh R. Barrett, Murray W. Huff |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
1999-06-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520335124 |
Similar Items
-
Ellagic Acid Suppresses ApoB Secretion and Enhances ApoA-1 Secretion from Human Hepatoma Cells, HepG2
by: Ayana Ieda, et al.
Published: (2021-06-01) -
Atorvastatin action involves diminished recovery of hepatic HMG-CoA reductase activity
by: Gene C. Ness, et al.
Published: (1998-01-01) -
Étude comparative de l'impact de la simvastatine et de l'atorvastatine, deux inhibiteurs de l'HMG-COA réductase, sur la cinétique in vivo de l'apolipoprotéine A-I chez l'homme
by: Mauger, Jean-François, et al.
Published: (2004) -
Hypocholesterolemic mechanism of phenolics-enriched extract from Moringa oleifera leaves in HepG2 cell lines
by: Peera Tabboon, et al.
Published: (2016-04-01) -
α-Tocopherol modulates the low density lipoprotein receptor of human HepG2 cells
by: Bottema Cynthia DK, et al.
Published: (2003-05-01)